US Office of National Drug Control Policy releases briefing on medication-assisted treatment

The US Office of National Drug Control Policy (ONDCP) has released a new briefing on options for the treatment of opioid dependence including guidance on the use of methadone and buprenorphine as medicines that have been approved for use by the US Food and Drug Administration.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.